Mihaela Ianosev, 43, a medical director with GSK Romania, was appointed European medical director of the critical illness business unit, a pan-European business unit part of GSK PharmaEurope, with offices in several major European countries.
The second person GSK takes to London is Roxana Precu, 36, who is set to work with the Arzerra (a drug used in leukemia treatment) team as a marketing director at GSK’s Oncology Center of Excellence.
Ianosev has worked with GSK Romania for 14 years and in 2002 became a member of the company’s board as a medical director. Precu started working with GSK in 2003 as a financial manager in Ukraine. Subsequently, she held several positions in GB and Romania.